RSV vaccine uptake will start slower than shingles shot: GSK CEO

Clinical Resources Archive

US FDA approves Pfizer RSV vaccine a month after greenlighting GSK shot

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO, ET HealthWorld

GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine

Vaccines for Children Program - Wikipedia

News - VaccineNation

Shingrix Archives - PharmaLive

UK house prices rise in January, Novo Nordisk obesity drug sales surge – as it happened, Business

GSK

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy (GSK)

Shingrix shingles vaccine protects seniors for 10 years, new data show

GSK's RSV vaccine bolsters bottom line, company raises full-year guidance

424B4

How a big pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits